Hrt Financial LP Biogen Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Biogen Inc. stock. As of the latest transaction made, Hrt Financial LP holds 89,217 shares of BIIB stock, worth $14.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

89,217

Holding current value

$14.4 Million

% of portfolio

0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $16.9 Million - $21.1 Million	89,217 New	89,217 $17.3 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $1.07 Million - $1.24 Million	3,896 New	3,896 $1.11 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $24.5 Million - $29.8 Million	97,102 Added 270.01%	133,064 $36.8 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $6.53 Million - $9.01 Million	33,545 Added 1387.88%	35,962 $9.6 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $797,045 - $947,835	-4,250 Reduced 63.75%	2,417 $492,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $715,011 - $900,876	3,690 Added 123.95%	6,667 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $566,741 - $728,345	-2,531 Reduced 45.95%	2,977 $714,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.13 Million - $2.78 Million	-7,531 Reduced 57.76%	5,508 $1.56 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $3.38 Million - $5.41 Million	13,039 New	13,039 $4.52 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $6.88 Million - $8.06 Million	-28,316 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $6.69 Million - $10.1 Million	28,316 New	28,316 $6.93 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $33.7 Million - $38.9 Million	-127,380 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $32.9 Million - $43.6 Million	127,380 New	127,380 $34.1 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $351,924 - $446,421	-1,309 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $7.47 Million - $10.3 Million	-33,929 Reduced 96.29%	1,309 $388,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $2.21 Million - $2.47 Million	-10,148 Reduced 22.36%	35,238 $8.2 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $9.95 Million - $11 Million	45,386 New	45,386 $10.6 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.68 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.62 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.34 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.18 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$825 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account